Michael Collins

Michael Collins is an experienced professional in the pharmaceutical industry with over two decades of expertise in quality management and product introduction. Currently serving as Director at AbbVie since November 2020, Michael oversees New Product Introduction Management, Qualified Person Batch Release, and Third Party Quality Management. Previous roles include Associate Director at Allergan from April 2016 to November 2020, and Qualified Person at Allergan from May 2015 to April 2016, where responsibilities similarly involved product introduction and quality oversight. Earlier experience includes positions at Mylan, GeneMedix plc, Schering-Plough Pharmaceuticals, and Procter & Gamble, where Michael developed skills in quality assurance, auditing, and production documentation. Michael holds a Master’s degree in Industrial Pharmaceutical Science from the Royal College of Surgeons in Ireland, a Bachelor’s degree with Distinction in Pharmaceutical Technology from Technological University Dublin, and a National Certificate in Science from Waterford Institute of Technology.